Northwestern Medicine and Vitestro Collaborate on Robotic Phlebotomy

Northwestern Medicine and Vitestro have announced a multi-year collaboration to advance automation in phlebotomy, announced in a press release. This partnership aims to address global staffing shortages and set a new standard for automated diagnostic blood collection.

As part of the collaboration, Northwestern Medicine will participate in a multicenter clinical trial to validate the performance and safety of Vitestro's Aletta, the world's first Autonomous Robotic Phlebotomy Device (ARPD). The study aims to generate key clinical evidence to support the adoption of automated phlebotomy as a scalable solution for U.S. hospital and outpatient blood draw centers.

The collaboration seeks to automate and standardize blood collection, addressing critical phlebotomy workforce shortages, enhancing operational efficiency, and improving sample quality and integrity. By doing so, it aims to expand access to high-quality blood collection while enhancing patient comfort and overall care.